InvestorsHub Logo

chevdawg18

05/22/20 7:36 AM

#22359 RE: NeverSettle #22358

A 23PE is stupid low. The S&P500 forward PE is generally around 16-19 and those are companies growing maybe on average at 4-8% y/y.

This is a legit, super fast growing OTC company (growing at over 100% y/y?)

No reason the PE should not be multiples higher than the S&P 500 multiple.

Honestly if your company is growing above 100% y/y ur multiple should be minimum 50 IMO.

Then once ur growth slows, so to does the multiple

snoof77

05/22/20 9:58 AM

#22362 RE: NeverSettle #22358

NeverSettle, thanks for the more accurate outstanding share information. I couldn't find the most recent numbers last night so used 2 financial sites that had the same outstanding share number. My calculations were just for one month so that's make some assumptions:

Net Income of $1,080,000 × 4 quarters gives you a rough forward projection of earning of $4,320,000.

Net Income of $4,320,000 divided by 1.35 billion shares (fully diluted) equals .O032 per share.

In that CAVR is rapidly growing we need to use the maximum OTC PE Ratio of 31.75 (It could be even higher based on growth potential. I'm thinking 45 to 1)

Conclusion:

.0032 income per share x 31.75 to 1 (maximum OTC PE Ratio) equals .1016 per share valuation.

.0032 income per share x 45.00 to 1 (potential PE Ratio based on rapid growth) equals .1440 per share valuation.

I don't believe that the company will enact a RS as I believe they are just up listing to the OTCX.

Just my humble opinion but clearly CAVR is severely undervalued.

Snoof77